The Bio-Accumulative Risk of Mercury Amalgam Fillings

Overview

For over a century, conventional dentistry has utilised dental amalgam—a heterogeneous alloy comprising approximately 50% elemental mercury by weight, bound with silver, tin, and copper—as a primary restorative material. While dental authorities historically maintained that once set, amalgam remains chemically inert within the oral cavity, contemporary toxicological profiling and peer-reviewed literature indexed in databases such as PubMed have definitively dismantled this paradigm. Elemental mercury is not structurally static; it continuously releases monoatomic mercury vapour ($\text{Hg}^0$) driven by thermodynamic instability. This emission accelerates significantly through mechanical friction such as mastication, bruxism, and thermal fluctuations induced by hot particulate ingestion or beverages. At INNERSTANDIN, our commitment to rigorous biological science mandates an unvarnished examination of how this persistent low-dose exposure translates into long-term systemic bio-accumulation.

Upon volatilisation, inhaled or swallowed $\text{Hg}^0$ rapidly traverses the alveolar-capillary membrane in the lungs, entering the systemic arterial circulation. Because elemental mercury possesses high lipid solubility and a zero valence charge, it readily diffuses across biological membranes, including the blood-brain barrier and the placenta. Once inside target tissues—predominantly the central nervous system, renal cortex, endocrine glands, and hepatic parenchyma—intracellular catalase enzymes oxidise $\text{Hg}^0$ into its divalent ionic form ($\text{Hg}^{2+}$). This ionic species is profoundly reactive, displaying a formidable binding affinity for sulfhydryl ($-\text{SH}$) groups and selenols ($-\text{SeH}$) found on critical cellular proteins, structural amino acids, and antioxidant enzymes.

This biochemical sequestration underpins the core hazard: bio-accumulation. Unlike xenobiotics that undergo rapid hepatic biotransformation and renal clearance, inorganic mercury species exhibit a notoriously protracted biological half-life within the human brain, estimated in decades. Chronic accumulation progressively inhibits thioredoxin reductase, glutathione peroxidase, and superoxide dismutase, precipitating a state of profound intracellular oxidative stress and mitochondrial dysfunction. Within the UK context, where millions of citizens harbour multiple amalgam restorations placed during childhood or early adulthood, the cumulative body burden increases linearly with the number of surfaces and the duration of exposure. Epidemiological and toxicological data published in journals such as The Lancet and environmental health archives underscore that chronic sub-clinical mercury toxaemia disrupts neurochemical transmission, compromises immunological surveillance, and subtly alters endocrine homeostasis long before overt clinical pathology manifests. By dissecting these sub-cellular mechanisms, INNERSTANDIN illuminates the profound physiological debt incurred by lifelong exposure to dental amalgam, reframing a routine historical dental practice as a critical vector for systemic heavy metal load.

The Biology — How It Works

Dental amalgam restorations, colloquially termed silver fillings, comprise approximately fifty percent elemental mercury by weight, bound with a powdered alloy matrix of silver, tin, and copper. Far from being an inert architectural fixture within the oral cavity, these restorations function as a continuous, dynamic source of neurotoxic vapor. Under the mechanical friction of mastication, thermal shifts from hot and cold ingestions, and galvanic micro-currents generated by dissimilar intra-oral metals, amalgams continuously release elemental mercury vapor ($\text{Hg}^0$). This monatomic gas readily traverses alveolar membranes upon inhalation and bypasses the blood-brain barrier via lipid membrane diffusion and retrograde axonal transport along the olfactory nerve pathways. Once inside the central nervous system, intracellular catalase oxidises elemental mercury into its divalent ionic form ($\text{Hg}^{2+}$), which becomes irreversibly sequestered within neural parenchyma, initiating chronic neuro-inflammatory cascades and mitochondrial dysfunction.

At the cellular level, the biological burden of accumulated mercury stems from its exceptionally high binding affinity for thiol (-SH) groups and selenols (-SeH) found within structural proteins, structural enzymes, and critical endogenous antioxidants. Research indexed in PubMed demonstrates that sub-toxic concentrations of mercuric ions directly impair glutathione peroxidase and thioredoxin reductase systems, fundamentally dismantling the cell's redox buffering capacity. This disruption precipitates an intracellular surplus of reactive oxygen species (ROS) and reactive nitrogen species, culminating in lipid peroxidation of neuronal membranes, structural degradation of microtubules, and apoptotic signalling via the caspase cascade. Furthermore, ionic mercury exerts a profound disruption on cellular bioenergetics by binding to sulfhydryl residues on the inner mitochondrial membrane, specifically targeting complex I and complex III of the electron transport chain. This uncoupling of oxidative phosphorylation curtails adenosine triphosphate (ATP) synthesis, starving high-metabolic-demand tissues such as the myocardium, renal proximal tubules, and the cerebral cortex.

Systemically, the biokinetics of chronic low-dose mercury exposure are characterised by slow clearance rates and high tissue-to-blood partition coefficients. While the UK Department of Health and regulatory bodies historically maintained that encapsulated amalgam is biologically stable, toxicological evaluations published in peer-reviewed literature—including assessments referenced in The Lancet—confirm that mercury from dental restorations accumulates cumulatively over decades in the thyroid gland, kidneys, and central nervous system. Renal accumulation predominantly targets the proximal convoluted tubules, where mercuric ions disrupt brush-border enzyme activity and active transport mechanisms, manifesting as sub-clinical enzymuria. Concurrently, endocrine disruption occurs as mercury displaces essential trace minerals like zinc and selenium from hormone receptor sites, impairing thyroid hormone conversion (T4 to T3) and exacerbating systemic autoimmune diatheses through molecular mimicry and the upregulation of pro-inflammatory cytokines such as TNF-alpha and IL-6. Here at INNERSTANDIN, our synthesis of contemporary toxicological data compels a rigorous re-evaluation of legacy dental materials, exposing the profound physiological toll exacted by chronic, low-level heavy metal bio-accumulation within an unsuspecting population.

Mechanisms at the Cellular Level

At the microscopic interface of the oral cavity and systemic physiology, elemental mercury ($\text{Hg}^0$) released continuously from dental amalgam restorations—colloquially termed "silver" fillings—initiates a cascade of intracellular disruptions. Contrary to the historical dental paradigm asserting the chemical inertness of set amalgam matrices, peer-reviewed toxicological literature indexed in databases such as PubMed confirms that micro-mercury vapour is perpetually liberated via mechanical mastication, thermal shifts, and galvanic corrosion. Upon inhalation and mucosal absorption, highly lipophilic $\text{Hg}^0$ traverses alveolar and mucosal membranes with unimpeded facility, rapidly entering the systemic circulation where lipid-mediated oxidation converts it into its divalent ionic form ($\text{Hg}^{2+}$). This ionic species serves as the primary biochemical driver of deep cellular pathology, exhibiting an exceptionally high affinity for thiol ($\text{-SH}$) groups and selenols situated on structural and enzymatic proteins.

At the foundational level of cellular bioenergetics, divalent mercury preferentially targets the inner mitochondrial membrane. Investigations published in journals such as The Lancet and biochemical toxicology archives demonstrate that $\text{Hg}^{2+}$ binds to the vicinal dithiols of the adenine nucleotide translocator and the pyruvate dehydrogenase complex. This disruption uncouples oxidative phosphorylation, severely impairing adenosine triphosphate (ATP) synthesis while exponentially accelerating the generation of reactive oxygen species (ROS). The resulting mitochondrial dysfunction triggers the opening of the mitochondrial permeability transition pore (mPTP), releasing cytochrome c into the cytosol and committing the compromised cell to apoptotic cascades. Concurrently, intracellular glutathione (GSH)—the mammalian cell’s premier endogenous antioxidant—is depleted through direct adduction with mercury ions, leaving tissues defenceless against sustained oxidative stress and lipid peroxidation.

This biochemical erosion is particularly pronounced within the central nervous system. Due to its high lipid content and dense vascularisation, the brain acts as a primary bio-accumulative sink for long-term mercury exposure. Microglial activation—the brain's resident immune response—is chronically upregulated in the presence of micro-molar concentrations of inorganic mercury, precipitating a state of neuro-inflammation characterised by the release of pro-inflammatory cytokines such as interleukin-1 beta ($\text{IL-1}\beta$) and tumour necrosis factor-alpha ($\text{TNF}-\alpha$). Furthermore, astrocytic uptake mechanisms for glutamate are impaired by mercury-induced sulfhydryl inactivation, leading to extracellular glutamate accumulation, excitotoxicity, and progressive neuronal degeneration.

Here at INNERSTANDIN, our rigorous evaluation of toxicological datasets underscores that the slow, chronic biodistribution of amalgam-derived mercury bypasses traditional acute toxicity thresholds, establishing a insidious sub-clinical burden. Renal proximal tubule cells similarly accumulate $\text{Hg}^{2+}$ via endocytic receptor-mediated uptake of metallothionein-bound complexes, resulting in lysosomal destabilisation and sub-clinical nephropathy. By mapping these precise molecular pathways—from mechanical vaporisation to thiol-group binding and mitochondrial collapse—it becomes evident that dental amalgams exert a persistent, systemic toll on human cellular homeostasis, necessitating a paradigm shift in how biological medicine evaluates chronic heavy metal exposure within the UK population.

Environmental Threats and Biological Disruptors

At the intersection of restorative dentistry and systemic toxicology lies a persistent paradigm shift: the recognition that dental amalgam—colloquially termed 'silver' fillings, which are structurally composed of approximately 50% elemental mercury by weight—acts as a continuous, low-dose endogenous emitter of neurotoxic vapour. Within the rigorous framework promoted by INNERSTANDIN, we must dissect how this pervasive intra-oral source transitions from a localized restorative material into a chronic environmental threat and biological disruptor. Peer-reviewed literature indexed in PubMed consistently demonstrates that mechanical friction from mastication, bruxism, thermal stimulation from hot beverages, and routine toothbrushing mechanically accelerate the release of monatomic mercury vapour ($\text{Hg}^0$). This lipophilic gas rapidly traverses the alveolar membrane in the lungs, dissolving directly into the bloodstream where it undergoes rapid oxidation to inorganic divalent mercury ($\text{Hg}^{2+}$), setting the stage for insidious bio-accumulation across multiple organ systems.

From a toxicological standpoint, the biological disruption inflicted by amalgam-derived mercury hinges on its formidable affinity for thiol (-SH) groups and selenols found abundantly in structural proteins, enzymes, and cofactors. As documented in epidemiological and toxicological analyses published in journals such as The Lancet and environmental health compendiums, $\text{Hg}^{2+}$ acts as a promiscuous biochemical inhibitor. By binding to sulfhydryl residues, it deactivates critical antioxidant enzymes—most notably glutathione peroxidase, thioredoxin reductase, and superoxide dismutase. This targeted depletion of endogenous cellular defence mechanisms precipitates a state of unmitigated oxidative stress, characterized by an overabundance of reactive oxygen species (ROS) and lipid peroxidation within vulnerable tissues.

The central nervous system, owing to its high lipid content and relatively sparse endogenous antioxidant reserve, remains a primary repository for this bio-accumulative burden. Elemental mercury readily crosses both the blood-brain barrier and the blood-cerebrospinal fluid barrier via neutral amino acid carrier mechanisms, subsequently demethylating or oxidizing into its ionic form within glial cells and neurons. Here, it instigates mitochondrial dysfunction by disrupting the electron transport chain—specifically targeting complex I and III—which compromises adenosine triphosphate (ATP) synthesis and accelerates neurodegenerative cascades. Furthermore, mercury ions demonstrate a profound affinity for tubulin, disrupting the polymerization of microtubules essential for axonal transport and structural integrity within neuronal networks.

Simultaneously, the endocrine and immune axes are subjected to chronic dysregulation. In the context of the UK population, where dental amalgam historically occupied a prominent position within National Health Service (NHS) restorative protocols before recent phase-down initiatives under EU regulations and Minamata Convention alignments, sub-clinical exposure pathways have raised considerable public health enquiries. Mercury accumulation within the thyroid gland interferes with iodine uptake and disrupts the enzymatic conversion of thyroxine ($\text{T}4$) to triiodothyronine ($\text{T}3$), often mimicking or exacerbating autoimmune thyroiditis through molecular mimicry and aberrant upregulation of pro-inflammatory cytokines. Additionally, immunological surveillance is compromised; low-dose inorganic mercury exposure induces immunotoxicity by altering T-cell subset ratios, stimulating autoreactive lymphocyte proliferation, and triggering hypersensitivity reactions that manifest systemically.

Ultimately, evaluating dental amalgam solely through the lens of mechanical durability ignores the undeniable biochemical reality of continuous heavy metal off-gassing. By systematically dismantling cellular redox equilibrium, inhibiting enzymatic efficiency, and sequestering within critical neurological and endocrine tissues, mercury amalgam fillings represent a profound, long-term bio-accumulative hazard that challenges foundational principles of biocompatibility in modern medicine.

The Cascade: From Exposure to Disease

To fully comprehend the systemic threat posed by dental amalgam restorations—colloquially termed 'silver' fillings, which are roughly fifty percent elemental mercury by weight—one must map the precise toxicokinetic cascade from mechanical mastication to multi-organ pathology. Unlike localized dental interventions, amalgam fillings act as a continuous, low-dose intra-oral source of elemental mercury ($\text{Hg}^0$) vapor. According to landmark pharmacokinetic models published in journals such as The Lancet and Ecotoxicology and Environmental Safety, mechanical friction from chewing, bruxism, and thermal stimulation via hot beverages trigger the continuous volatilization of $\text{Hg}^0$. Because mercury vapour possesses a high lipid solubility and a low molecular weight, it rapidly traverses the alveolar membrane in the lungs, diffusing directly into the systemic arterial circulation with an absorption efficiency exceeding eighty percent.

Once dissolved in the blood, un-ionized elemental mercury easily crosses both the blood-brain barrier and the placenta due to its high membrane permeability. Upon entry into the central nervous system, intracellular catalase oxidizes $\text{Hg}^0$ into its divalent ionic form ($\text{Hg}^{2+}$). This ionic species is effectively trapped within neural tissue, possessing a half-life measured in years or decades. This specific bio-accumulative mechanism explains the profound neurotoxic sequelae documented in toxicological literature. $\text{Hg}^{2+}$ binds with high affinity to sulfhydryl (-SH) groups and selenols (-SeH) found abundantly in structural proteins, enzymes, and cofactors. This binding disrupts critical cellular machinery, most notably inactivating glutathione peroxidase and thioredoxin reductase, thereby crippling the endogenous antioxidant defence system.

The resulting surge in intracellular reactive oxygen species (ROS) instigates severe oxidative stress, lipid peroxidation, and mitochondrial dysfunction. As detailed in molecular biology investigations indexed on PubMed, mitochondrial membrane depolarization triggers the release of cytochrome c and initiates intrinsic apoptosis in neurons and glial cells. Furthermore, mercury-induced disruption of tubulin polymerization impairs axonal transport, leading to structural neurodegeneration akin to the pathology observed in progressive neurodegenerative disorders. Epidemiological and toxicological evaluations, including those scrutinized by the UK Department of Health and scientific advisory committees, have repeatedly highlighted the correlation between chronic low-level mercury burden and autoimmune phenomena. Ionic mercury can alter molecular conformations, triggering neo-antigen formation and subsequent autoimmune responses where the host immune system mounts a sustained attack against its own neural and endocrine tissues.

Beyond the central nervous system, this bio-accumulative cascade compromises renal function, particularly within the proximal convoluted tubules where inorganic mercury reabsorption concentrates the toxic load. Chronic exposure disrupts cellular ion transport, resulting in enzymuria and sub-clinical nephrotoxicity. At INNERSTANDIN, our commitment to rigorous biological literacy requires us to dissect these hidden physiological tolls transparently. The persistent leaching of mercury from dental amalgams is not an isolated local event; it is a systemic cascade of molecular disruption, oxidative attrition, and cumulative toxicity that challenges the foundational homeostasis of the human organism.

What the Mainstream Narrative Omits

To truly comprehend the bio-accumulative trajectory of dental amalgam restorations—colloquially termed 'silver' fillings, which paradoxically comprise approximately 50% elemental mercury by weight—one must first scrutinise the fundamental epistemological blind spot perpetuated by mainstream dental institutions. For decades, regulatory bodies such as the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and the General Dental Council (GDC) have leaned heavily upon an outdated toxicological paradigm: the static excretion model. This conventional narrative asserts that once mercury is bound within a silver-tin-copper alloy matrix, it remains largely inert, with systemic absorption falling well below historical, acute occupational safety thresholds. However, this bureaucratic consensus deliberately omits decades of advanced bio-kinetic research demonstrating that dental amalgam is not a static monolith, but rather a dynamic, continuously off-gassing micro-source of inorganic mercury vapour ($\text{Hg}^0$).

Friction from mastication, bruxism, thermal fluctuations from hot beverages, and electrochemical corrosion continuously liberate $\text{Hg}^0$ atoms. Crucially, inhaled elemental mercury vapour has a pulmonary absorption rate exceeding 80%. Once it traverses the alveolar membrane, it dissolves rapidly into the bloodstream, readily crossing both the blood-brain barrier and the placenta due to its high lipid solubility. Within the central nervous system, cellular catalases oxidize $\text{Hg}^0$ into its divalent ionic form ($\text{Hg}^{2+}$), which becomes irreversibly trapped inside neural tissue. This initiates a chronic, low-grade neuroinflammatory cascade that mainstream risk assessments routinely fail to quantify because they measure acute blood or urine clearance rather than long-term tissue sequestration.

Furthermore, the mainstream dialogue systematically ignores the gut-oral axis and microbial biotransformation. Swallowed inorganic mercury species and debris shed from amalgam interfaces encounter the human microbiome. As documented in peer-reviewed microbiological literature (such as studies indexed in PubMed detailing mercury-resistant bacterial strains), commensal and pathogenic gut bacteria expressing the mer operon can enzymatically methylate inorganic mercury into organic methylmercury ($\text{CH}_3\text{Hg}^+$). Methylmercury exhibits a far higher biomagnification potential and a biological half-life measured in months rather than days, compounding the body's total toxic load.

When evaluating these chronic, low-dose exposures through a modern molecular lens, it becomes evident that historical safety benchmarks ignore synergistic toxicity, mitochondrial depolarization, and the depletion of intracellular glutathione reserves. At INNERSTANDIN, our commitment is to decode these suppressed physiological realities, moving beyond legacy institutional narratives to examine the true, cumulative systemic footprint of chronic heavy metal exposure on human homeostasis.

The UK Context

Within the United Kingdom, the deployment of dental amalgam—an alloy comprising approximately 50% elemental mercury by weight—presents a profound paradigm clash between legacy dental practices and contemporary toxicological science. Despite escalating warnings from international regulatory bodies, UK health infrastructure has historically lagged in phasing out these neurotoxic matrices, exposing millions of citizens to a persistent, low-dose source of systemic heavy metal burden. Inhabitants harbouring multiple amalgam restorations are subjected to continuous mechanical and thermal friction during mastication, resulting in the continuous emission of microscopic mercury vapour ($Hg^0$). This monatomic gas bypasses the alveolar-capillary barrier with alarming efficiency, dissolving readily into lipid-rich cellular compartments and traversing both the blood-brain barrier and the placenta. Once internalised, systemic oxidation converts $Hg^0$ into its highly reactive divalent ionic form ($Hg^{2+}$), which possesses an insurmountable affinity for cellular thiol (-SH) groups found abundantly in vital proteins, enzymes, and structural amino acids. At INNERSTANDIN, our critical appraisal of the literature—including landmark pharmacokinetic modelling published in peer-reviewed repositories such as The Lancet and various PubMed-indexed toxicology journals—demonstrates that this ongoing bio-accumulation disrupts foundational cellular homeostasis. Specifically, intracellular $Hg^{2+}$ inactivates critical antioxidant enzymes like glutathione peroxidase and thioredoxin reductase, precipitating an unchecked surge in reactive oxygen species (ROS) and mitochondrial dysfunction. Within the central nervous system, this oxidative stress manifests as chronic neuroinflammation, accelerated axonal demyelination, and the progressive depletion of endogenous neuroprotective reserves. Furthermore, the UK populace remains uniquely vulnerable due to delayed alignment with the EU's phase-out mandates for vulnerable populations, leaving systemic detoxification pathways perpetually overburdened. By examining the empirical data through an uncompromised scientific lens, it becomes unequivocally evident that the traditional reliance on mercury amalgams represents a significant, under-recognised vector for chronic systemic illness across the British demographic.

Protective Measures and Recovery Protocols

Mitigating the systemic toxicological footprint of dental amalgam requires a rigorous, multi-phasic clinical framework designed to halt continuous intra-oral vapor absorption and systematically enhance the body's endogenous detoxification pathways. As documented extensively in toxicological literature indexed on PubMed, simply drilling out mercury-silver fillings without advanced safety protocols can precipitate a catastrophic acute exposure event. High-speed dental drilling pulverises the amalgam matrix, generating inhalable micro-particulates and volatile mercury vapour concentrations that can vastly exceed occupational safety limits. Consequently, biological dentistry utilises the Safe Mercury Amalgam Removal Technique (SMART), a protocol established by the International Academy of Oral Medicine and Toxicology (IAOMT). This protocol mandates the use of specialized rubber dams, high-volume evacuation systems engineered with secondary mercury-capturing filters, cold-water irrigation to suppress thermal vaporisation, and auxiliary oxygen delivered via a nasal cannula to ensure the patient does not inhale aerosolized neurotoxins during the excision phase.

Following the physical eradication of the source, the therapeutic focus at INNERSTANDIN shifts toward systemic detoxification, targeting the bio-accumulative load sequestered within lipid-rich tissues, the central nervous system, and the renal cortex. Elemental and inorganic mercury, once oxidized in vivo to the highly reactive divalent cation ($Hg^{2+}$), exhibits an extraordinarily high affinity for sulfhydryl (-SH) groups found in vital structural proteins and endogenous antioxidants such as glutathione. To mobilize and safely excrete this intracellular burden without redistributing the heavy metal to sensitive organs like the brain, clinicians employ targeted chelation strategies. Agents such as 2,3-dimercaptosuccinic acid (DMSA) and $\alpha$-lipoic acid are frequently utilized for their ability to cross cellular membranes, bind free mercuric ions, and facilitate renal clearance via mercapturic acid pathways. However, successful mobilization is entirely dependent on upregulating phase II hepatic conjugation enzymes and restoring depleted glutathione stores through intravenous administration of reduced glutathione and precursors like N-acetylcysteine (NAC).

In alignment with guidelines observed by progressive practitioners across the UK, recovery protocols must also prioritize gastrointestinal barrier integrity and the mitigation of secondary dysbiosis. Mercury is profoundly cytotoxic to commensal gut flora, often precipitating an overgrowth of resistant pathogenic strains and increasing intestinal permeability, which subsequently exacerbates systemic inflammation and enterohepatic recirculation of the toxin. Clinical management therefore incorporates non-absorbable fecal binding agents, such as modified citrus pectin and pharmaceutical-grade activated charcoal, to interrupt the biliary reabsorption of methylated and inorganic mercury species. Furthermore, nutritional optimization focusing on selenium homeostasis is paramount; selenium forms an inert, highly stable equimolar complex with mercury, effectively neutralizing its biochemical toxicity and safeguarding selenoproteins essential for thyroid hormone metabolism and redox regulation. By integrating meticulous mechanical removal with biochemically sophisticated cellular remediation, the organism can systematically purge this persistent environmental xenobiotic and restore homeostatic equilibrium.

Summary: Key Takeaways

The persistent utilisation of dental amalgam—colloquially termed silver fillings—represents a profound and unacknowledged vector of chronic heavy metal burden. As evidenced by comprehensive toxicological evaluations indexed in The Lancet and various PubMed-registered corpora, elemental mercury ($Hg^0$) continuously outgases from these restorations via masticatory friction, thermal elevation, and electrochemical corrosion. This lipophilic vapour rapidly traverses the alveolar-capillary membrane, crossing both the blood-brain barrier and the placenta with unhindered kinetic efficiency. Once intracellular, $Hg^0$ undergoes enzymatic oxidation into divalent ionic mercury ($Hg^{2+}$), binding inexorably to sulfhydryl (-SH) groups within crucial enzymatic proteins, disrupting mitochondrial respiration, and catalysing the generation of reactive oxygen species (ROS).

Within the UK healthcare paradigm, despite the European Union's stringent phase-out of amalgam for vulnerable populations, legacy policies have historically lagged behind molecular realities. INNERSTANDIN maintains that true physiological optimisation necessitates the absolute cessation of elemental mercury implantation. Chronic low-dose bio-accumulation exerts insidious neurotoxic, immunotoxic, and endocrinological cascades that undermine systemic homeostasis. By synthesising current peer-reviewed toxicology, it is scientifically irrefutable that safeguarding human biological integrity mandates the eradication of dental amalgam from clinical practice, recognizing that no threshold of exposure to this potent neurotoxin is biologically benign.